NCT03126903View on ClinicalTrials.gov

A Clinical Study to Evaluate the KeraKlear Keratoprosthesis in Patients With Corneal Opacity

NATerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Corneal Blindness
Interventions
DEVICE

KeraKlear Non-Penetrating Keratoprosthesis

The KeraKlear is a flexible non-penetrating artificial cornea designed to be implanted through small corneal incisions in subjects with corneal opacity.

Trial Locations (4)

27710

Duke University School of Medicine - Dept. of Ophthalmology, Durham

41017

Cincinnati Eye Institute, Edgewood

92697

University of California Irvine, Irvine

02114

Massachussetts Eye and Ear Infirmary, Boston

Sponsors

Lead Sponsor

KeraMed, Inc.
All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

collaborator

ClinReg Consulting Services, Inc.

OTHER

lead

KeraMed, Inc.

INDUSTRY